NewAmsterdam Pharma (NAMS) Soars 93.9% in 12 Months
NewAmsterdam Pharma Co. N.V. (NASDAQ:NAMS) is a late-stage biopharmaceutical company dedicated to transforming the treatment of cardiovascular and…
Teva Pharma (TEVA) Wins FDA Approval for UZEDY’s Bipolar I Expansion
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the world’s largest and most established pharmaceutical companies, headquartered in…
Radiopharm Theranostics (RADX) Halts Trading Ahead of Major Capital Raise
Radiopharm Theranostics Limited (NASDAQ:RADX) is an Australian-based clinical-stage biotechnology company pioneering advancements in radiopharmaceuticals for both diagnostic imaging…
Candel Therapeutics (CADL) Boosts Cash to $217M, Prepares for 2026 Prostate Cancer Launch
Candel Therapeutics, Inc. (NASDAQ:CADL) is a clinical-stage biopharmaceutical company pioneering the next generation of cancer immunotherapies by harnessing…
Teladoc (TDOC)’s AI Upgrade Could Be Its Biggest Breakthrough Since Livongo
Teladoc Health Inc. (NYSE:TDOC) is a global leader in virtual healthcare and telemedicine, widely recognized as the company…
Tonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is a clinical-stage biopharmaceutical company headquartered in Chatham, New Jersey, dedicated to discovering,…
AstraZeneca (AZN) Targets $80 Billion Revenue by 2030
AstraZeneca PLC (NASDAQ:AZN) is one of the world’s largest and most influential biopharmaceutical companies, built on a legacy…
Akero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street
Akero Therapeutics, Inc. (NASDAQ:AKRO) is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on developing…
Molina Healthcare (MOH) Crashes 39% in a Year
Molina Healthcare Inc. (NYSE:MOH) is a leading managed care company in the United States that provides health insurance…
Tenax Therapeutics (TENX) Fully Funded Through 2027 With $105.5M Cash
Tenax Therapeutics Inc. (NASDAQ:TENX) is a late-stage clinical biopharmaceutical company committed to transforming the treatment landscape for patients…
Inside Galectin (GALT)’s $18 Billion Shot at Reversing Liver Cirrhosis
Galectin Therapeutics Inc. (NASDAQ:GALT) is a clinical-stage biotechnology company headquartered in Norcross, Georgia, pioneering the development of novel…
Tvardi Therapeutics (TVRD) Could Be 2025’s Most Democratic Biotech Stock
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) is a clinical-stage biotechnology company redefining the boundaries of targeted therapy through its pioneering…
Anavex (AVXL) Gains as $120M Cash Fuels Next Alzheimer’s & Schizophrenia Trials
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a cutting-edge clinical-stage biopharmaceutical company focused on discovering and developing novel therapies…
Aldeyra Therapeutics (ALDX) Falls Below $5.40 as FDA Decision Looms
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) is a Massachusetts-based clinical-stage biotechnology company focused on discovering and developing novel therapies designed…
Fresenius Medical (FMS) Hovers Near $22 — But For How Long?
Fresenius Medical Care AG (NYSE:FMS) is the world’s leading provider of dialysis products and services for individuals with…
Labcorp (LH) Trades Near $210 as Investors Bet on 82% Earnings Boom
Laboratory Corporation of America Holdings (NYSE: LH), commonly known as Labcorp, is one of the world’s leading global…
Axogen (AXGN) Surges Toward $26 Target as Nerve Repair Demand Soars 17%
Axogen Inc. (NASDAQ:AXGN) is a leading regenerative medicine company focused on advancing the science and clinical practice of…
Emergent BioSolutions (EBS) Faces Investor Pressure After Revenue Drops to $0.81B TTM
Emergent BioSolutions Inc. (NYSE:EBS) is a global life sciences company headquartered in Gaithersburg, Maryland, known for developing, manufacturing,…